GNC10821

GNC10821 eDiary App

The GNC10821 eDiary App has been developed to collect eDiary information for patients registered in the GENC10821 protocol. This study is a randomized, double-blind, placebo-controlled clinical trial of GEN 003 in subjects who have received previous doses of GEN-003.

*Note: this app requires an activation code and can only be accessed by patients who are participating in the GNC10821 trial.